CONSENSO SOBRE CONTRACEÇÃO 2020

Contraceção Hormonal e Intrauterina com Condições Médicas Especiais | DOENÇAS PSIQUIÁTRICAS | D8
BIBLIOGRAFIA
1. Hall, K. S., Steinberg, J. R., Cwiak, C. A., Allen, R. H. & Marcus, S. M.
Contraception and mental health: a commentary on the evidence and
principles for practice. American Journal of Obstetrics and Gynecology
212, 740–746 (2015).
2. Curtis, K. M. et al. U.S. Medical Eligibility Criteria for Contraceptive Use,
2016. MMWR. Recommendations and reports: Morbidity and mortality
weekly report. Recommendations and reports / Centers for Disease Control
65, (2016).
3. Faculty of Sexual & Reproductive Healthcare. Uk Medical Eligibility
Criteria. (2016).
4. WHO. Medical eligibility criteria for contraceptive use. WHO (2015).
5. Robakis, T., Williams, K. E., Nutkiewicz, L. & Rasgon, N. L. Hormonal
Contraceptives and Mood: Review of the Literature and Implications
for Future Research. Current Psychiatry Reports 21, (2019).
6. Lewis, C. A. et al. Effects of Hormonal Contraceptives on Mood: A
Focus on Emotion Recognition and Reactivity, Reward Processing,
and Stress Response. Current Psychiatry Reports 21, (2019).
7. Pagano, H. P., Zapata, L. B., Berry-Bibee, E. N., Nanda, K. & Curtis, K.
M. Safety of hormonal contraception and intrauterine devices among
women with depressive and bipolar disorders: a systematic review.
Contraception 94, 641–649 (2016).
8. Worly, B. L., Gur, T. L. & Schaffir, J. The relationship between progestin
hormonal contraception and depression: a systematic review.
Contraception 97, 478–489 (2018).
9. ACOG. Clinical Management Guidelines for Obstetrician – Gynecologists:
Use of hormonal contraception in women with coexisting medical
conditions. Obstetrics & Gynecology 133, 128–150 (2019).
10. Rapkin, A. J., Korotkaya, Y. & Taylor, K. C. Contraception counseling for
women with premenstrual dysphoric disorder (PMDD): current perspectives.
Open Access Journal of Contraception Volume 10, 27–39 (2019).
11. Edelman, A. et al. contraceptives for contraception (Review). (2014).
doi:10.1002/14651858.CD004695.pub3.www.cochranelibrary.com
12. Ti, A. & Curtis, K. M. Postpartum hormonal contraception use and
incidence of postpartum depression: a systematic review. The European
Journal of Contraception & Reproductive Health Care 24, 109–116 (2019).
13. Sociedade Portuguesa da Contraceção, S. P. de M. do A. & S. P. de
P. Contraceção na adolescência: Recomendações para o Aconselhamento
na adolescência. (2016).
14. Maïmoun, L. et al. Oral contraceptives partially protect from bone
loss in young women with anorexia nervosa. Fertility and sterility 111,
1020-1029.e2 (2019).
15. Merki-Feld, G. S. & Bitzer, J. Contraception in adolescents with anorexia
nervosa. Is there evidence for a negative impact of combined hormonal
contraceptives on bone mineral density and the course of the
disease? The European Journal of Contraception & Reproductive Health
Care 25, 213–220 (2020).
16. Seeman, M. V. & Ross, R. Prescribing contraceptives for women
with schizophrenia. Journal of Psychiatric Practice 17, 258–269 (2011).
17. Lozano, M., Obiol, M. A., Peiró, J., Iftimi, A. & Ramada, J. M. Professional
counseling in women with serious mental illness: achieving a
shift toward a more effective contraceptive method. Journal of Psychosomatic
Obstetrics and Gynecology 0, 1–7 (2020).
18. Oliver, R. Contraceptive and sexual health care issues in women
with schizophrenia. Journal of Family Planning and Reproductive Health
Care 39, 289–291 (2013).
105